These findings are consistent with studies of head and neck cancer and colon cancer, in which GCS inhibition down-regulates MDR1 expression and induces ceramide-mediated apoptosis in cisplatin-resistant cells [41,48]. This evidence concerns the gene ABCB1 and head and neck cancer.